[A cholesterol embolism during heparin treatment]

Area of Science:

• Cardiovascular Medicine
• Pathology

Background:

• Cholesterol embolization syndrome (CES) is a rare but serious complication of atherosclerosis.
• The role of anticoagulant therapy, specifically heparin, in the etiology of CES has been debated, often considered an adjuvant factor during procedures.

Observation:

• A 60-year-old patient with ischemic cardiomyopathy developed CES.
• Diagnosis was confirmed via cutaneous biopsy during heparin treatment.
• The patient experienced a favorable spontaneous evolution requiring only limited lower limb amputations.

Findings:

• The authors propose a direct link between heparin administration and the onset of cholesterol emboli in this patient.
• No other causative factors were identified to explain the occurrence of CES.

Implications:

• This case highlights a potential direct iatrogenic cause of CES related to heparin therapy.
• Further investigation into the interaction between anticoagulants and atherosclerotic plaque rupture is warranted.
• Understanding this relationship may refine patient management and reduce CES incidence.